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journal homepage: www.elsevier.com/locate/ihjAortic valve stenosis constitutes of 5–6% of all congenital heart
defects. Its prevalence is higher in males than in females.
While the pathology of stenosis is variable, it is most
commonly a bicuspid valve with fusion of the valve commis-
sures. Unicuspid aortic valves are more common in the
neonate with critical obstruction whereas bicuspid valves are
common in childhood, adolescence, and adulthood.1 Truly
tricuspid valves are not common. The degree of aortic stenosis
increases with increasing age. The management of congenital
aortic valve stenosis was by surgical valvotomy in the past, but
with the advent of balloon aortic valvuloplasty (BAV),2,3 it has
become the initial option in the treatment of congenital aortic
stenosis (AS).4,5 It should be understood that the natural
history, reaction to treatment, and prognosis for congenital
aortic valve stenosis are strikingly different from those seen
with calciﬁc AS of the elderly.
Following successful adaptation of balloon angioplasty
techniques of Dotter,6 Gruntzig,7 and their associates to treat
aortic coarctation and pulmonary valve stenosis in children,
Lababidi and his colleagues2,3 extended the technique of
balloon valvuloplasty to aortic valve stenosis. Subsequently,
a number of cardiologists have applied this technique
and reported their results, extensively referenced else-
where.4,5,8–13 In this issue of the Journal, Awasthy and
associates14 evaluate long-term results of BAV with particu-
lar attention to adolescent and adults. They compared the
outcomes of this subset with those of children below 1 year of
age and those between 1 and 11 years. The need for repeat
BAV (10.3–18.1%), presence of aortic regurgitation, grade 3 or
more (9–9.6%) and need for surgery (2.4–3.6%) at follow-up
were examined and found to be similar ( p > 0.19) in all three
age groups. The authors conclude that long-term outcome in
the adults and adolescents is similar to that in infants and
children, and BAV is an obvious treatment of choice in
adolescent and adults.
This is a well written paper addressing the mid-term
(median of 3 years), although the authors call it long-term
outcome, of BAV of congenital aortic valve stenosis, particu-
larly pointing out that the outcome in adults is similar to that
observed in infants and children. This is particularly timely,
given the enthusiasm which many centers are exhibiting for§ From the Department of Pediatrics, Division of Pediatric Cardiologytranscatheter aortic valve replacement (TAVR). The TAVR
should be reserved for calciﬁc AS of the elderly and the non-
calciﬁc AS in adolescents and adults could be addressed
adequately by the less invasive balloon valvuloplasty.
An extensive search of the literature (PubMed) of BAV
revealed over 500 papers since the Lababidi's publications2,3 in
early 1980s; most of these address calciﬁc AS of the elderly15,16
or immediate and short-term follow-up after BAV. The long-
term results, deﬁned as more than a mean (or median) follow-
up of 5 years, are scanty and are listed in Table 1.10,17–26 Several
other investigators27,28 reported the results of BAV in
adolescents and adults, but did not reach the criteria for
inclusion in the table. As can be seen by examining the table, a
substantial proportion of patients had re-intervention during
the follow-up period with actuarial re-intervention-free rates
of nearly 50% at 10 years. The re-interventions were for
recurrent AS either by repeat BAV or surgery, depending upon
the institutional preference. The aortic insufﬁciency (AI) has
been addressed either by surgical repair or replacement of
aortic valve, again depending upon the institutional prefer-
ence. It is prudent to address the causes of AS and AI and
examine whether they could be prevented.
1. Aortic valve restenosis
Based on the follow-up results,8,10 using multivariate
stepwise logistic regression analysis, we identiﬁed age ≤3
years at the time of valvuloplasty and immediate post-
valvuloplasty peak-to-peak aortic valve gradient ≥30 mmHg
as predictive factors for restenosis. Several other studies
have since made similar observations. The inﬂuence of
various technical and morphological features on the results
of BAV was examined by Sholler and colleagues,29 but no
statistical signiﬁcance was demonstrated for any factors
tested. It is quite possible that the morphology of the aortic
valve and the balloon/annulus ratio may play a key role in
restenosis at follow-up, but further studies are necessary to
establish such a relationship.
It is important to ensure that the balloon is appropriately
centered across the aortic valve during BAV since there is a
tendency for ejection of the balloon during the balloon, UT Health McGovern Medical School, Houston, TX, United States.
Table 1 – Long-term results after balloon aortic valvuloplasty.
Authors/ref. Number of
subjects
Age at valvuloplasty
(mean  SD)
Duration of
follow-up
(mean  SD)
Country Long-term results
Hawkins et al.17 60 7.3  6 years 1–110 months USA 38% required surgery at 44  37 months after
BAV (AI in 13 and AS in 10).
Actuarial freedom from surgical intervention
was 70%  6% at 5 years and 51%  12% at
9 years.
Kuhn et al.18 22 61  23 months. USA 45% required re-intervention after BAV
(AI in 3 and AS in 7).
Freedom from re-intervention was 75% at
100 months.
Galal et al.10 26 6 weeks to 20 years 3–9 years
(median 6 years)
Saudi Arabia
and USA
23% had restenosis and underwent surgical
(4 patients) or repeat BAV (2 patients).
Actuarial intervention-free rates at 5 and
9 years were 76% and 76% respectively.
Demkow et al.19 55 3.5–23 years
(11.7  4.5)
62  30 months Poland 33.3% re-intervention 51  24 months after
BAV (AI in 6 and AS in 5).
Actuarial freedom from re-intervention at
6 and 8 years was 61% and 56% respectively.
Jindal et al.20 74 1–20 years 5.5  2.9 years India 14% had re-intervention.
Actuarial intervention-free rates at 5, 7 and
12 years were 92.9%, 84.4% and 60%,
respectively.
Reich et al.21 269 0–23 years
(median 8 months)
Median 5.3 years Czech
Republic
20.1% needed surgery. Valvuloplasty failure
occurred in 41.6%.
Probability of surgery-free survival was 50% at
14.4 years after BAV
Fratz et al.22 120 5.8  5.9 yearsa Up to 17.5 years Germany 12% had repeat BAV for recurrent AS and 23%
had surgery for AI.
Freedom from aortic valve surgery at 10 years
was 59%.
Brown et al.23 509 Median = 2.4 years
(1 day to 40.5 years)
Median 9.3 years USA 23% had repeat BAV, 13% had aortic valve
repair and 23% had aortic valve replacement.
Freedom from aortic valve replacement was
90% at 5 years, 79% at 10 years, and 53% at
20 years.
Maskatia et al.24 272 1 day to 30.5 years 5.8  6.7 years USA 15% had repeat valvuloplasty (balloon or
surgical); 15% had aortic valve replacement;
9% had heart transplantation or death.
Rossi et al.25 31 2–92 days Mean 81 months Brazil 24% patients required surgery during
follow-up.
Survival free from aortic valve surgery was
66% at 63 months and 50% at 80 months.
Soulatges et al.26 93 Mean 2.4 years
(1 day to 18 years)
11.4  7 years Belgium Freedom from surgery at 5, 10, and 20 years
was 82%, 72%, and 66%, respectively.
AI, aortic insufﬁciency; AS, aortic stenosis; BAV, balloon aortic valvuloplasty; SD, standard deviation.
a Babies <1 month were excluded from the table.
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 5 9 2 – 5 9 5 593procedure. Use of stiff guide wires and long balloons were
considered adequate in the most of our patients.4,5,8–10 Use of
adenosine-induced transient cardiac standstill30 or rapid right
ventricular pacing31 to achieve stable position of the balloon
during BAV may become necessary in some patients to ensure
appropriate positioning of the balloon.
2. Aortic insufﬁciency
AI was noted as a signiﬁcant long-term complication after
BAV and requires surgical repair of the valve or valve
replacement. The majority of the studies show a trend towardincrease in the degree of AI with time; the longer the follow-
up, the greater is the AI. The reasons for progression of AI are
not well understood. The hypotheses put forward include
greater relief of gradient immediately following BAV,32
Doppler-quantiﬁed AI both prior to and immediately follow-
ing BAV,10 unicommissural aortic valves,29 aortic valve
prolapse,33 poor valve morphology,10 and large balloon/
annulus ratio.29,34 Our studies10 indicate that balloon/annu-
lus ratio may not be related to AI (Fig. 1A), but the degree of AI
immediately after BAV (Fig. 1B) is predictive of development
of signiﬁcant late AI. Further studies to explore these and
other causes for development of late AI and device methods to
prevent AI are in order.
Fig. 1 – (A) Relationship between the balloon/annulus ratio
and degree of aortic insufficiency (AI) at late follow-up.
Note that there is no correlation with an r value of 0.36. (B)
Relationship between the degree of aortic insufficiency (AI)
immediately following balloon aortic valvuloplasty with AI
at late follow-up. Note that there is a significant correlation
with an r value of 0.71.
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In summary, the paper by Awasthy is an excellent contribu-
tion to our knowledge of BAV and clearly points out the BAV
is as good a treatment option for adolescents and adults with
congenital aortic valve stenosis as for neonates, infants and
children. This is particularly timely given the enthusiasm for
TAVR and help us to consider BAV for treatment of
congenital aortic valve stenosis in adolescents and adults
and reserve TAVR for calciﬁc AS of the elderly. Recurrence of
AS at follow-up can usually be treated with repeat BAV. The
predictors of recurrence are young age (≤3 years) and high
residual gradients (≥30–40 mmHg) immediately following
BAV. AI seems to be problematic at late follow-up and
requires surgical intervention. The degree of immediate
post-valvuloplasty AI grade may be predictive of late AI.
Because of late development of AI, requiring surgical
intervention, it is prudent to strictly adhere to indications
for BAV and not to perform balloon valvuloplasty for milder
or borderline gradients.Conﬂicts of interest
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